Yes. But not likely. In most cases that I have seen are typically pharmaceuticals. They are typically high risk/high reward based on clinical trial results. This one is more conservative. With that said, they are moving pretty fast. I think in a few quarters "yes". Lots to do before getting to that point but I see it happening. In a few weeks, I would say "no". This is an investment not a pump and dump.